Inactive Instrument

ZINZINO Stock Swiss Exchange

Equities

SE0002480442

Other Specialty Retailers

End-of-day quote Swiss Exchange
- SEK - Intraday chart for ZINZINO
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site
Sales 2024 * 1.92B 177M Sales 2025 * 2.06B 191M Capitalization 2.8B 259M
Net income 2024 * 179M 16.57M Net income 2025 * 195M 18.05M EV / Sales 2024 * 1.57 x
Net Debt 2024 * 221M 20.46M Net Debt 2025 * 158M 14.62M EV / Sales 2025 * 1.43 x
P/E ratio 2024 *
16.2 x
P/E ratio 2025 *
14.9 x
Employees -
Yield 2024 *
2.44%
Yield 2025 *
2.13%
Free-Float 53.08%
More Fundamentals * Assessed data
Managers TitleAgeSince
Chief Executive Officer 54 11-12-31
Director of Finance/CFO 47 08-12-31
Chief Tech/Sci/R&D Officer 48 17-12-31
Members of the board TitleAgeSince
Director/Board Member 60 06-12-31
Director/Board Member 56 -
Director/Board Member 52 -
More insiders
Zinzino AB is a Sweden-based global Company engaged in selling dietary supplements, skin care and lifestyle products. The Company specializes in biomarker-based, personalized nutrition and health tech. The Company’s test-based, scientifically proven nutritional supplements are available on more than 100 markets across the world. Zinzino AB owns the Norwegian research and production units BioActive Foods AS and Faun Pharma AS. The Company’s headquarter is in Gothenburg, Sweden with additional offices in Finland, Latvia, Norway, USA, Australia, Hong Kong, Malaysia and India.
Calendar
More about the company
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW